Pylum Biosciences, Inc.
PrivateLast Round
Seed
Mar 5, 2020
Total Funding Raised
$962,000
Company Overview
Pylum Biosciences, Inc. operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Grant round in January 2019.
Pylum Biosciences, Inc. is a biotechnology company that develops precision anti-bacterial technology and bactericidal protein complexes targeting specific bacterial pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pylum Biosciences, Inc. Comparables
Compare Pylum Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eligo Bioscience | 82% | |
| Locus Biosciences | 81% | |
| BiomX Inc. | 74% |
For institutional investors. Book with your work email.
Pylum Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 5, 2020 | ||||
| Grant | Jan 28, 2019 |
For institutional investors. Book with your work email.
Pylum Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2024
Grew 300% QoQ from 1 to 4 employees.
- Mar 5, 2020
$990K raised in Seed round.
For institutional investors. Book with your work email.
Pylum Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pylum Biosciences, Inc.'s valuation, stock price, and market status.
Is Pylum Biosciences, Inc. a public or private company?
Pylum Biosciences, Inc. is a private company.
What is the current stock price of Pylum Biosciences, Inc.?
Pylum Biosciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Pylum Biosciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pylum Biosciences, Inc. worth (valuation)?
Valuation information for Pylum Biosciences, Inc. is not publicly available.
Can I buy Pylum Biosciences, Inc. stock?
Pylum Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pylum Biosciences, Inc.'s last funding round?
Pylum Biosciences, Inc.'s most recent funding round was Seed on March 5, 2020.
Who are the main investors in Pylum Biosciences, Inc.?
Key investors in Pylum Biosciences, Inc. include National Institute of Allergy and Infectious Diseases.
Will Pylum Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Pylum Biosciences, Inc..
How can I track Pylum Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Pylum Biosciences, Inc.'s shares on secondary markets.